Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Healthy Participants
In brief
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-892216-LAI in healthy adults.
Key facts
- Study ID
- NCT07093580
- Run by
- Shionogi
- People needed
- 98
- Starts
- 2025-07-29
- Expected to finish
- 2027-05-26
- Last updated by the study team
- 2025-08-27
Who can join
Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.
Where it is running
- ICON Clinical Research: Lenexa — Lenexa, Kansas, United States (enrolling)
- ICON Clinical Research: Salt Lake City — Salt Lake City, Utah, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.